-
摘要: 目的探讨人胎盘提取液对高脂饮食性脂肪性肝病的治疗作用及其机理。方法42只Wistar大鼠,雄性,分为正常对照组(n=8,予普通标准饲料)和模型组(n=34,予高脂饮食,建立大鼠脂肪肝模型)喂饲12周后,将模型组随机分为造模组(n=8)、人胎盘提取液高剂量组(n=9)、人胎盘提取液低剂量组(n=9)、易善复对照组(n=8)。4周后取血和肝组织。肝组织HE染色观察病理学改变,用放免法检测各组大鼠血浆及肝组织中Leptin、TNF-α、IL-6的含量。结果人胎盘提取液低剂量组和易善复组较造模组有好转,但无明显差异(P>0.05),人胎盘提取液高剂量组脂肪浸润状态较造模组有明显好转,且差异有统计学意义(P<0.05)。造模组大鼠血浆中Leptin、TNF-α、IL-6的含量均高于正常对照组(P<0.05),人胎盘提取液高、低剂量组、易善复对照组较造模组明显降低(P<0.05);血浆及肝组织溶浆中IL-6,TNF-α及Leptin的含量之间均无显著相关性。结论人胎盘提取液对Leptin、TNF-α、IL-6等细胞因子具有明显的抑制作用,对高脂饮食脂肪性肝病动物模型具有明显...Abstract: Objective To investigate the effects and mechanisms of human placenta extracts to rats with nonalcoholic fatty liver disease.Methods Forty-two male Wistar rats were randomly divided into two groups: blank control group (n=8, fed by ordinary standard diet) and fatty-liver group (n=34, the fatty-liver models were established by feeding with high-fatty diet by a term of 12-week) .Then the fatty-liver models were randomly scarified for model group (n=8) , human placenta high dose group (n=9) , human placenta low dose group (n=9) and Essentiale group (n=8) .By the end of 4th week, histological examinations of liver were carried out with HE staining;meanwhile, the serum and tissue levels of Leptin、TNF-α、IL-6 were detected with RIA.Results The fatty degeneration in livers with low dose human placenta extracts and Essentiale were slightly milder than that of the models (P>0.05) .While high dose human placenta could obviously lessen the fatty degeneration (P<0.05) .Compared with the blank control group, the serum and tissue levels of Leptin、TNF-αand IL-6 in the model group were all remarkably increased (P<0.05) .And the human placenta and Essentiale could significantly lower the levels of Leptin、TNF–α and IL-6 (P<0.05) .There were no typical relevance between the contents of Leptin、TNF-α and IL-6 both in serum and liver tissue.Conclusion Human placenta extracts is effective in treating fatty liver disease induced by high-fatty diet.This may be due to its effects in lowering the levels of the cytokines such as Leptin、TNF-αand IL-6.
-
Key words:
- Placenta extracts /
- Fatty liver disease /
- Leptin /
- Tumor necrosis factor /
- IL-6
-
[1]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志, 2003, 11 (2) ∶71. [2]Farrell GC.Non-alcoholic steatohepatitis:what is it, and why is itimportant in the Aisa-Pacific region[J].J Gastoonterol Hepatol, 2003, 18∶124-138. [3]Caldwell SH, Hespenheide EE.Subacute liver failure in obesewomen[J].Am J Gastroenterol, 2002, 97∶2058-2062. [4]Chikako N, Zhang shu-ping, John R V.Polymorphisms of micro-somal triglyceride transfer protein gene and manganese superoxidedismutase gene in non-alcohlic steatohapetitis[J].J Hepatol, 2004, 40∶781-786. [5]崔文姬, 杨景文, 吕忠智.胎盘提取液影响脂蛋白—胆固醇代谢的实验研究[J].中国临床药理学与治疗学, 2000, 5 (2) :127-130.
本文二维码
计量
- 文章访问数: 2055
- HTML全文浏览量: 10
- PDF下载量: 734
- 被引次数: 0